Cure My Disease

Don't miss your cure!

 Log in / Sign up

Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test

NCT ID NCT02447159

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether giving small cash payments to HIV-positive pregnant women in Nigeria can encourage them to stay in care and reduce the chance of passing HIV to their babies. Women who register their pregnancy, pick up their medication, deliver at a clinic, and get their newborn tested receive payments. The study compares these women to those receiving standard care to see if the cash incentives improve health outcomes for both mothers and infants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
conditional cash transfers
What this could lead to
If it works, this approach could offer a simple, scalable way to keep more HIV-positive mothers and their babies healthy in low-resource settings.
What could go wrong
This is a single trial in one region of Nigeria, so results may not apply elsewhere. Cash incentives may not address other barriers to care, such as stigma or transportation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

554 people

The number who actually took part.

Started

Aug 2015

Finished

Apr 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HIV positive * Pregnant * Attended an antenatal care visit at one of three participating clinics. Exclusion Criteria: * Not HIV positive * Not pregnant * Not registered for antenatal care at a participating clinic.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Infant, Newborn, Diseases Patient Acceptance of Health Care perinatal disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV HIV infections Infant, newborn, diseases Pregnancy

Contacts and locations

Locations

  • General Hospital, Ikot Ekpene

    Ikot Ekpene, Akwa Ibom State, Nigeria

  • General Hospital, Iquita Oron

    Oron, Akwa Ibom State, Nigeria

  • Immanuel General Hospital

    Eket, Akwa Ibom State, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.